Akash Mourya | Health and Medicine Advances | Best Researcher Award

Published on by New Scientists

Mr. Akash Mourya | Health and Medicine Advances | Best Researcher Award

PhD Scholar | National Institutes of Pharmaceutical Education and Research | India

Mr. Akash Mourya is a promising young pharmacologist specializing in pharmacology and toxicology, with a strong research focus on liver pathophysiology, hepatoprotective drug discovery, and molecular mechanisms underlying hepatic and pulmonary disorders. His ongoing Ph.D. work at NIPER Mohali builds on extensive preclinical and translational research conducted at the Institute of Liver and Biliary Sciences (ILBS), New Delhi, where he has developed expertise in animal models of liver diseases, hemodynamic studies, and hepatic cell culture systems. His research contributions have advanced understanding of non-alcoholic and alcoholic fatty liver diseases, hepatopulmonary and porto-pulmonary hypertension, and liver regeneration mechanisms. He has co-authored seven peer-reviewed publications in high-impact journals, including Journal of Hepatology, JHEP Reports, American Journal of Physiology–Gastrointestinal and Liver Physiology, npj Gut and Liver, ACS Omega, and Life Sciences. His work has collectively received 31 citations, 7 Documents, with an h-index of 3, reflecting growing recognition within the biomedical research community. In addition to journal articles, Mr. Akash Mourya has contributed two book chapters published by Springer Nature (2024) and Academic Press (2025), covering topics such as oxidative stress and pharmacological interventions in liver disease, and PPARγ signaling in diabetes. His research abstracts have been presented at prestigious international conferences, including the American Association for the Study of Liver Diseases (AASLD) and the European Association for the Study of the Liver (EASL). His work integrates pharmacological innovation, molecular biology, and experimental therapeutics, with emphasis on Ayurvedic formulations, CB2 receptor agonists, and novel siRNA nanoparticle delivery systems. Mr. Akash Mourya’s ongoing efforts contribute to translational R&D for liver protection and regeneration, aligning with India’s growing emphasis on integrative pharmacology and precision medicine.

Profiles: Scopus | Google Scholar | ResearchGate | PubMed 

Featured Publications

1. Baweja, S., Kumari, A., Negi, P., Tomar, A., Tripathi, D. M., Mourya, A. K., Rastogi, A., Subudhi, P. D., Thangariyal, S., Kumar, G., Kumar, J., Sood, A., Vashistha, C., Bihari, C., Maiwall, R., & Sarin, S. K. (2023). Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimod. Journal of Hepatology, 79(1), 167–180.

2. Juneja, P., Rahman, S. N. R., Jakhar, D., Mourya, A. K., Tripathi, D. M., Kaur, I., Tiwari, V., & others. (2023). Recombinant VEGF-C (Cys156Ser) improves mesenteric lymphatic drainage and gut immune surveillance in experimental cirrhosis. JHEP Reports, 5(10), 100816.

3. Biswas, S., Yadav, N., Juneja, P., Mourya, A. K., Kaur, S., Tripathi, D. M., & Chauhan, V. S. (2022). Conformationally restricted dipeptide-based nanoparticles for delivery of siRNA in experimental liver cirrhosis. ACS Omega, 7(41), 36811–36824.

4. Kaur, I., Juneja, P., Tiwari, R., Vasudevan, A., Mourya, A. K., Trauner, M., Sarin, S. K., & Tripathi, D. M. (2024). Secondary bile acids in portal blood contribute to liver regeneration in a rat model of partial hepatectomy. American Journal of Physiology – Gastrointestinal and Liver Physiology, 327(4), G645–G658.

5. Tripathi, D. M., Singh, P., Mourya, A. K., & Kaur, S. (2024). Oxidative medicine and novel pharmacological treatment approaches in liver disease. In Adaptation under stressful environments through biological adjustments and interventions (pp. 311–334). Springer Nature.

 

Seema Kandalkar | Health and Medicine Advances | Best Researcher Award

Published on by New Scientists

Ms. Seema Kandalkar | Health and Medicine Advances | Best Researcher Award

Student, Sanjivani College of Pharmaceutical Education and Research, Kopargaon (SPPU), India

Ms. Seema Kandalkar is a dedicated pharmaceutical researcher currently serving as an IPR Trainee at Trexo Global Pvt. Ltd, Nashik, and is affiliated with Sanjivani College of Pharmaceutical Education and Research (SPPU). She completed her M. Pharmacy in Pharmaceutics from Sanjivani College of Pharmaceutical Education and Research, Kopargaon, in 2025, following a B. Pharmacy from Pravara Rural Education Society College of Pharmacy (SPPU, 2023). Her research primarily focuses on formulation and development of innovative drug delivery systems, including probiotic and effervescent tablet formulations, with emerging interests in regulatory affairs and intellectual property rights. She has gained significant hands-on experience through her industrial projects and internships at Sci-Tech Efferceuticals (R&D), Sanpras Healthcare Pvt. Ltd., and Reve Pharma, where she honed practical skills in analytical techniques, GMP, stability studies, dissolution testing and drug delivery design. Among her key contributions, she successfully developed and evaluated a probiotic effervescent tablet during her M. Pharmacy project and has disseminated her findings via a review article accepted in Journal of Future Foods (ScienceDirect, IF 7.2), along with poster presentations at international conferences and participation in national-level research competitions. Her work has been recognized for its academic rigor and innovative approach in pharmaceutical sciences, earning accolades through national seminars and competitive workshops. Professionally, she is skilled in Microsoft Office Suite, BioRender and Zotero and actively participates in scientific workshops and seminars. Author metrics for Ms. Seema Kandalkar include 1 published document with citation potential, currently reflecting initial scholarly impact. Her work contributes to advancing formulation science, promoting effective healthcare solutions, and strengthening pharmaceutical innovation and intellectual property awareness. Her vision encompasses enhancing patient-centric drug delivery, fostering regulatory excellence and contributing to global pharmaceutical research standards. With her blend of academic excellence, industrial exposure and research innovation, Ms. Seema Kandalkar is well-positioned to make significant contributions to pharmaceutical sciences and healthcare innovation internationally.

Profile: ORCID | ResearchGate | LinkedIn

Featured Publications

1. Kandalkar, S. T., Shendge, R. S., & Lohakare, O. K. (2025). Unveiling the therapeutic potential of probiotics: A review. Journal of Future Foods. Advance online publication.

 

Yiling Hou | Health and Medicine | Best Researcher Award

Published on by New Scientists

Prof. Dr. Yiling Hou | Health and Medicine | Best Researcher Award

Professor, China West Normal University, China

Prof. Dr. Yiling Hou is a distinguished scientist and Professor at the College of Life Sciences, China West Normal University, recognized as a reserve candidate for academic and technological leadership in Sichuan Province and an overseas high-level talent. She earned her Bachelor of Science in Pharmacy (2005) and Master of Science in Medicinal Chemistry (2008) from Sichuan University, followed by a Doctor of Science in Biochemistry and Molecular Biology (2011) from Sichuan Agricultural University and further enhanced her expertise as a visiting scholar at the Perelman School of Medicine, University of Pennsylvania (2017–2018). Beginning her career as a Teaching Assistant in 2008, she advanced to Lecturer in 2011, Associate Professor in 2011 and full Professor in 2016, also serving as Program Director for Biotechnology (2013–2020) and currently as Deputy Director of the Sichuan Collaborative Innovation Center for Tissue Repair Materials Engineering Technology. Her research focuses on the isolation, purification, structural identification and biological activity of fungal polysaccharides, alongside tumor cell kinetics, spindle dynamics during mitosis, meiosis and the molecular mechanisms underlying cancer progression. Skilled in structural identification, molecular medicine, apoptosis analysis and advanced biopharmaceutical techniques, she has published 104 Scopus-indexed papers with 787 citations and an h-index of 16, reflecting her growing international impact. Prof. Dr. Yiling Hou is an active Councilor of the Sichuan Provincial Microbiology Society and the Sichuan Provincial Youth Federation, highlighting her commitment to scientific community leadership and youth engagement. Honored as an emerging academic leader in Sichuan Province, she continues to guide students and collaborative projects that bridge traditional pharmacology and modern oncology. With her strong publication record, leadership roles and global collaborations, Prof. Dr. Yiling Hou is poised to make transformative contributions to cancer research and molecular therapeutics, advancing biomedical science and inspiring future generations of researchers.

Profile: Scopus | ResearchGate | Sci Profiles | Scilit

Featured Publications

1. Wang, Y., Lu, R., Ding, X., You, Y., Lin, Y., Hou, Y., & Xia, Y. (2025). Structure identification and in vitro immunomodulatory activities of polysaccharide AHL26-P from Arachis hypogaea (Tianfu 26) leaves. Results in Chemistry, 18, 102724.

2. Sun, Z.-A., Zhao, N., Zheng, L., Pan, F., Ding, X., & Hou, Y. (2025, June 26). Comparative studies on the structure and biological activities of two new polysaccharides from Tricholoma flavovirens (TF-P) and Trametes versicolor (TV-P). Results in Chemistry. Advance online publication.

3. Liu, K., Sun, Z., Li, X., Qing, X., Yu, W., Liu, M., Ding, X., & Hou, Y. (2025). Structure characterization and biological activity of polysaccharides from Trametes sanguinea (TS-P) and wild Lentinus edodes (LE-P). Food Bioscience, 68, 106656.

4. Zhou, L., Ding, X., & Hou, Y. (2024). The structure characterization and biological activities of new polysaccharides from Armillariella tabescens (AT-P) and Tricholoma portentosum (TP-P). Results in Chemistry, 18, 4620–4633.

5. Yu, W., Yuan, R., Liu, M., Liu, K., Ding, X., & Hou, Y. (2024). Effects of rpl1001 gene deletion on cell division of fission yeast and its molecular mechanism. Current Issues in Molecular Biology, 46(3), 2576–2597.